Aditya Asokan

Aditya joined Samsara in 2020. During his time at Samsara, Aditya has been involved in both, private and public company investments, a number of Samsara’s internal company creation efforts, and currently serves as an Observer for Fluent Biosciences, ImmunOs Therapeutics, and a stealth stage oncology company. Aditya is a neuroscientist by training and has spent over 10 years conducting research on Parkinson’s Disease, Autism Spectrum Disorders, and neuroinflammation. Prior to Samsara, Aditya was a Postdoctoral Fellow and Research Scientist at Stanford University School of Medicine. Outside the lab, Aditya also consulted for various life science investment firms such as Aquilo Capital Management and Sofinnova Investments and is a founding member of the Mythos Biotechnology Fund, a student and postdoc-led life science investment club at Stanford. Aditya received a Ph.D. in Biomedical Engineering from the University of Florida and is an alumnus of the Stanford Graduate School of Business Ignite Program in entrepreneurship and innovation.